239 related articles for article (PubMed ID: 18304793)
21. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.
Lee CY; Tien HF; Hu CY; Chou WC; Lin LI
Br J Cancer; 2007 Oct; 97(7):877-82. PubMed ID: 17848952
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.
Zhou WB; Bai M; Jin Y
Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801
[TBL] [Abstract][Full Text] [Related]
23. Angiogenic cytokines in serum and cutaneous lesions of patients with polyarteritis nodosa.
Kikuchi K; Hoashi T; Kanazawa S; Tamaki K
J Am Acad Dermatol; 2005 Jul; 53(1):57-61. PubMed ID: 15965421
[TBL] [Abstract][Full Text] [Related]
24. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
[TBL] [Abstract][Full Text] [Related]
25. Levels of soluble vascular endothelial growth factor receptor 1 are elevated in the exudative pleural effusions.
Tomimoto H; Yano S; Muguruma H; Kakiuchi S; Sone S
J Med Invest; 2007 Feb; 54(1-2):146-53. PubMed ID: 17380026
[TBL] [Abstract][Full Text] [Related]
26. Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
Konstantinovsky S; Nielsen S; Vyberg M; Kvalheim G; Nesland JM; Reich R; Davidson B
Breast Cancer Res Treat; 2005 Nov; 94(1):71-80. PubMed ID: 16142438
[TBL] [Abstract][Full Text] [Related]
27. The peritoneal cavity is a distinct compartment of angiogenic molecular mediators.
Nachtsheim R; Dudley B; McNeil PL; Howdieshell TR
J Surg Res; 2006 Jul; 134(1):28-35. PubMed ID: 16650862
[TBL] [Abstract][Full Text] [Related]
28. Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression.
Kurschat P; Eming S; Nashan D; Krieg T; Mauch C
Br J Dermatol; 2007 Apr; 156(4):653-8. PubMed ID: 17263813
[TBL] [Abstract][Full Text] [Related]
29. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia.
Keith T; Araki Y; Ohyagi M; Hasegawa M; Yamamoto K; Kurata M; Nakagawa Y; Suzuki K; Kitagawa M
Br J Haematol; 2007 May; 137(3):206-15. PubMed ID: 17408459
[TBL] [Abstract][Full Text] [Related]
30. Potential role of soluble angiopoietin-2 and Tie-2 in patients with inflammatory bowel disease.
Koutroubakis IE; Xidakis C; Karmiris K; Sfiridaki A; Kandidaki E; Kouroumalis EA
Eur J Clin Invest; 2006 Feb; 36(2):127-32. PubMed ID: 16436095
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.
Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR
Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110
[TBL] [Abstract][Full Text] [Related]
32. [Role of C-C chemokines in the determination of pleural effusion etiology].
Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
Pneumonol Alergol Pol; 2008; 76(6):415-20. PubMed ID: 19173189
[TBL] [Abstract][Full Text] [Related]
33. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
[TBL] [Abstract][Full Text] [Related]
34. [Vascular endothelial growth factor in benign and malignant pleural effusions].
Kaya A; Poyraz B; Celik G; Ciledag A; Gulbay BE; Savas H; Savas I
Arch Bronconeumol; 2005 Jul; 41(7):376-9. PubMed ID: 16029730
[TBL] [Abstract][Full Text] [Related]
35. High level of vascular endothelial growth factor in hemorrhagic pleural effusion of cancer.
Ishimoto O; Saijo Y; Narumi K; Kimura Y; Ebina M; Matsubara N; Asou N; Nakai Y; Nukiwa T
Oncology; 2002; 63(1):70-5. PubMed ID: 12187074
[TBL] [Abstract][Full Text] [Related]
36. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of proangiogenic cytokines in children with lymphomas.
Mizia-Malarz A; Sobol G; Janowska J; Wos H; Zahorska-Markiewicz B
Pediatr Blood Cancer; 2009 Dec; 53(7):1195-9. PubMed ID: 19621434
[TBL] [Abstract][Full Text] [Related]
38. [Pleural fluid to serum cholinesterase ratio to discriminate between transudates and exudates: reevaluation in 177 patients].
García Pachón E; Padilla Navas I; Molina Siles M; López-Azorín F
Rev Clin Esp; 1998 Mar; 198(3):129-32. PubMed ID: 9586433
[TBL] [Abstract][Full Text] [Related]
39. Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema.
Bishara J; Goldberg E; Ashkenazi S; Yuhas Y; Samra Z; Saute M; Shaked H
Ann Thorac Surg; 2009 Jan; 87(1):251-4. PubMed ID: 19101307
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control.
Qian Q; Zhan P; Sun WK; Zhang Y; Song Y; Yu LK
Neoplasma; 2012; 59(4):433-9. PubMed ID: 22489699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]